APLIF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Appili Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.007 USD

Market Cap: $848.9k

A	Appili Therapeutics Inc OTC:APLIF	CA
E	Ekipa Holding SA WSE:EEE	PL
	Edenred SE PAR:EDEN	FR
	Appili Therapeutics Inc TSX:APLI	CA
I	IL & FS Investment Managers Ltd NSE:IVC	IN
P	Pacific Metals Co Ltd SWB:PYV	JP
T	Taylor Wimpey PLC DUS:TWW	UK
	Hitachi Construction Machinery Co Ltd F:HCMA	JP
T	Taylor Wimpey PLC F:TWW	UK
	Universal Electronics Inc NASDAQ:UEIC	US
	Ilsung Pharmaceutical Co Ltd KRX:003120	KR
S	Sentia ASA F:Z9P	NO
	Ishihara Sangyo Kaisha Ltd TSE:4028	JP
	Butn Ltd ASX:BTN	AU

Profitability Summary

Appili Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 666%

Negative 3Y Average Operating Margin

-2 643%

Declining Operating Margin

-1 248% > -1 666%

Negative Net Margin

-1 294%

Negative 3Y Average Net Margin

-1 329%

Declining Net Margin

-1 166% > -1 294%

Negative Free Cash Flow Margin

-378%

Negative 3Y Average Free Cash Flow Margin

-127%

Free Cash Flow Margin is Increasing

-651% > -378%

Exceptional ROE

28%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

274%

Declining ROIC

842% > 135%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.